| Product NDC: | 0074-6463 |
| Proprietary Name: | Gengraf |
| Non Proprietary Name: | Cyclosporine |
| Active Ingredient(s): | 25 mg/1 & nbsp; Cyclosporine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0074-6463 |
| Labeler Name: | AbbVie Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065003 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100524 |
| Package NDC: | 0074-6463-32 |
| Package Description: | 30 CAPSULE in 1 BLISTER PACK (0074-6463-32) |
| NDC Code | 0074-6463-32 |
| Proprietary Name | Gengraf |
| Package Description | 30 CAPSULE in 1 BLISTER PACK (0074-6463-32) |
| Product NDC | 0074-6463 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Cyclosporine |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100524 |
| Marketing Category Name | ANDA |
| Labeler Name | AbbVie Inc. |
| Substance Name | CYCLOSPORINE |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |